Clinigen forms alliance with Cumberland Pharmaceuticals

The alliance will combine Clinigen’s and Cumberland’s respective strengths, expertise and geographical footprints to maximize the commercial potential of future products.

As part of Clinigen’s continuing strategy to extend its global presence, this collaboration will build on Clinigen’s existing North American relationships by providing complementary support from Cumberland in the development, marketing, promotion and distribution of future products in the US.

Clinigen will be responsible for the marketing, promotion, distribution and sale of selected Cumberland pharmaceutical products, enabling Cumberland to use Clinigen’s strong international reach to enter in to new markets outside of the US.

Clinigen Group CEO Peter George said: "A key strategic initiative this year has been to develop our Group’s global distribution footprint. The US is a particular area of focus where we are looking to initiate a long term strategic partnership and Cumberland was a natural fit as a partner. Working together is a logical move for both companies as we will mutually benefit from each other’s distribution expertise and capabilities in our respective regions."

Cumberland chairman and CEO AJ Kazimi said: "This alliance with Clinigen creates a new growth driver for both companies that builds on our strengths. We look forward to working closely with Clinigen to bring its future products to patients in the US through our established commercial infrastructure. In turn, our products will gain access to new markets in other parts of the world."